MSTN and sarcopenia: Elevated TNF-α in turn stimulates the expression of myostatin, which can cause muscle atrophy by activating proteasome-mediated intracellular protein catabolism (Sriram et al., 2011) (Figure 2), suggesting that inhibiting myostatin-triggered ROS can reduce muscle wasting associated with sarcopenia.